Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

No link between topical steroids and fracture risk found in children with atopic dermatitis

Key clinical point: Children diagnosed with atopic dermatitis (AD) prior to age 4 years who are prescribed topical corticosteroids have no significantly increased fracture risk.

Major finding: Evaluated as a time-dependent covariate, the use of a topical corticosteroid was associated with a nonsignificant 17% increased risk of fracture (hazard ratio, 1.17; P = .16).

Study details: A population-based study of 7,505 patients diagnosed with AD prior to age 4 years.

Disclosures: The researchers reported having no financial disclosures.


Imhof R et al. SPD 2020, poster abstract.